Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Outcomes of Percutaneous Intramyocardial Septal Radiofrequency Ablation Treating for Hypertrophic Obstructive Cardiomyopathy: A Large-Sample Study

NCT07003945 is registered in ClinicalTrials.gov with Xijing Hospital as lead sponsor.

NCT NCT07003945
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07003945 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Outcomes of Percutaneous Intramyocardial Septal Radiofrequency Ablation Treating for Hypertrophic Obstructive Cardiomyopathy: A Large-Sample Study
Lead sponsor
Xijing Hospital
Phase
Observational
Overall status
Active, not recruiting
Start date
April 29, 2025
Completion date
June 30, 2027
Enrollment
800 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypertrophic obstructive cardiomyopathy (hocm)